comprehensive care of advanced (T4) rectal cancer (Dr. Fu Chuangang, Shanghai) and excellent presentations of the experience with and outcome of selective inter-sphincteric rectal resection (Dr. Du Jinlin, Jinhua) and extralevator rectal resection (the ELAPE procedure; Dr. Wang Zhenjun, Shenyang).
Additional special presentations included a tactical approach to the diagnosis and management of Crohn's disease (Dr. Gu Yunfei, Liaonin) and a similar evaluation of strategies in the treatment of severe constipation (Dr. Liu Baohua, Beijing). Two further special presentations were made by Professor Long Cui (Shanghai) concerning planning considerations for impending molecular and genetic coloproctological research (given China's considerable resources and facilities for tissue banking) and by Professor Wang Jianping (Guangzhou) who at the start of the meeting outlined the future direction of colorectal surgery in China. The principles highlighted by Professor Wang aim to standardize colorectal resectional techniques across China and to develop a nationwide cooperative colorectal cancer network which will foster clinical research.
The meeting was of high quality and excellently organized with an expanded emphasis on minimally invasive approaches along with the definition of national strategic protocols for the management of inflammatory bowel disease, complex perirectal sepsis and functional bowel disorders. The future of Chinese coloproctology seems assured with a plan spearheaded by Professor Long Cui and his colleagues which will enhance Chinese-led research and will strengthen international collaboration. It is certainly worth placing this congress in one's calendar so as to gain a greater insight into the evolution of Chinese coloproctology and to foster scientific and publishing partnerships.
